ExcelMab Overview
- Founded
- 2016
- Status
- Private
- Latest Deal Type
- Series A1
- Investors
- 6
ExcelMab General Information
Description
Developer of cancer therapeutics. The company's pharmaceutical products aim to treat and reduce symptoms of various kinds of cancers, enabling healthcare professionals to prescribe more effective treatments to their patients.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
- Room 511, 5th Floor, Building B10
- No.11 Kaiyuan Avenue, Huangpu District
- Guangzhou, Guangdong
- China
+86 020 0000 0000
ExcelMab Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A1) | 11-Mar-2020 | Completed | Startup | |||
| 1. Early Stage VC (Series A) | 01-Jan-2018 | Completed | Startup |
ExcelMab Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Wenjun Zhang | Chief Executive Officer & Founder |
ExcelMab Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Caijin Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| CAS Investment Management | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Korea Investment Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Medfine Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Oriza Holdings | Fund of Funds | Minority | 000 0000 | 000000 0 |